Human T-cell leukemia virus

Retroviruses Human T-cell leukemia virus (HTLV) Human T-lymphocytic tumors... 

Kalyanaraman, D. Mann, G. D. Sidhu, R. E. Stahl, S. Zolla-Prazner, J. Leibowitch, and M. Popovic, Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS), Science 220 865 (1983). 

Kobe B, Center RJ, Kemp BE, Poumbouris P. 1999. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc Natl Acad Sci USA 96 4319-4324. 

Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Ohshiro K, Mori N. 2006. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. Int J Cancer 118 765-772. 

Baskerville, S., Zapp, M. and Ellington, A.D. (1995) High-resolution mapping of the human T-Cell leukemia virus type 1 rex-binding element by in vitro selection. J. Virol., 69, 7559-7569. 

Bogerd, H.P., Echarri, A, Ross, T.M. and Cullen, B.R. (1998) Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crml. J. Virol, 72, 8627-8635. 

Bogerd, H.P., Fridell, R.A., Benson, R.E. and Cullen, B.R. (1996) Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by an in vivo randomization-selection assay. Mol. Cell. Biol., 16, 4207-A214. 

Kitajima, I., Shinohara, T., Minor, T., Bibbs, L., Bilakovics, J. and Nerenberg, M. (1992) Human T-cell leukemia virus type 1 tax transformation is associated with increased uptake of oligodeoxynucleotides in vitro and in vivo. J. Biol. Chem., 267, 25881-25888. 

FC EMEA FDA GCP GMO HAP HEPA HIV HTLV ICH European Commission European Medicines Agency Food and Drug Administration good clinical practices genetically modified organisms hamster antibody production high efficiency particulate air human immunodeficiency virus human T-Cell leukemia virus International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use... 

Akagi T, Takeda I, Oka T, Ohtsuki Y, Yano S, Miyoshi I (1985) Experimental infection of rabbits witlr human T-cell leukemia virus type I. Jpn J Cancer Res 76 86—94. 

Biddison WE, Kubota R, Kawanishi T, Taub DD, Cruikshank WW, Center DM, Cormor EW, Utz U, Jacobson S (1997) Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from padents with HTLV-I-associated neurologic disease secrete proin-flanimatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 159 2018-2025. 

Fujisawa J, Seiki M, Kiyokawa T, YoshidaM (1985) Funcdonal acdvadon of the long terminal repeat of human T-cell leukemia virus type I by a d ans-acdng factor. Proc Natl Acad Sci USA 82 2277— 2281. 

Hakata Y, Yamada M, Shida H (2001) Rat CRMl is responsible for the poor activity of human T-cell leukemia virus type 1 Rex protein in rat cells. J Virol 75 11515—11525. 

Hanabuchi S, Ohashi T, Koya Y, Kato H, Hasegawa A, Takemura E, Masuda T, Kannagi M (2001) Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model Peptide-induced T-cell immunity. J Nad Cancer hist 93 1775—1783. 

Iwakui a Y, Saijo S, Kioka Y, Nakayama-Yamada J, Itagaki K, Tosu M, Asano M, Kanai Y, Kakimoto K (1995) Autoimmunity inducdon by human T cell leukemia virus type 1 in ti ansgenic mice diat develop chronic inflammatory ardn opadiy resembling rheumatoid ai dii ids in humans. J Immunol 155 1588—1598. 

Kindt TJ, Said WA, Bowers FS, Maliana W, Zliao TM, Simpson RM (2000) Passage of human T-cell leukemia virus type-1 dui ing progi ession to cutaneous T-cell lymphoma results in myelopadiic disease in an HTLV-1 infecdon model. Microbes hifect 2 1139—1146. 

Miyoshi I, Yoshimoto S, Kubonishi I, Fujishita M, Ohtsuki Y, Yamashita M, Yamato K, Hrrose S, Taguchi H, Niiya K, et al. (1985) Infecdous dansmission of human T-cell leukemia virus to rabbits. Int J Cancer 35 81-85. 

Mord eux F, Kazanji M, Gabet AS, de Thoisy B, Wattel E (2001) Two-step nature of human T-cell leukemia virus type 1 replica don in experimentally infected squirrel morrkeys (Saimiri sciureus). J Virol 75 1083-1089. 

Ohaslii T, Hanabuclii S, Kato H, Koya Y, Takemura F, Hirokawa K, Yoshiki T, Tanaka Y Fuji M, Kannagi M (1999) hrduchon of adult T-cell leukemia-like lymphoproliferahve disease and its inliibition by adoptive immunotlieraphy in T-cell-deficient nude rats inoculated witli syngeneic human T-cell leukemia virus type 1-immortalized cells. J Virol 73 6031-6040. 

Pique C, Uieta-Vidal A, Gessain A, Chanceiel B, Gout O, Tamouza R, Agis F, Doklielai MC (2000) Evidence for die cln onic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral pepddes. J Exp Med 191 567-572. 

Ricliai dson JH, Edwaids AJ, Cruickshank JK, Rudge P, Dalgleish AG (1990) In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 64 5682—5687. 

Simpson RM, Leno M, Hubbard BS, BGiidt TJ (1996) Cutaneous mauifestadons of human T cell leukemia virus type I infecdon in an experimental model. J hifect Dis 173 722—726. 

Kazanji M, Ureta-Vidal A, Ozden S, Tangy F, de Thoisy B, Fiette L, Talar-min A, Gessain A, de The G (2000) Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saitniri sciureus) Provirus expression, persistence, and humoral and cellular immune responses. J Virol 74 4860-4867. 

Kiyokawa T, Seiki M, Iwashita S, Imagawa K, Shimizu F, Yoshida M (1985) p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc Natl Acad Sci U S A 82 8359-8363. 

---